Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors

Cancer Res. 2000 Mar 1;60(5):1221-4.

Abstract

Neoplastic transformation of glial cells alters inclusion of the alpha exon in human fibroblast growth factor receptor-1 (FGFR-1) mRNA transcripts. Although normal cells predominantly include the alpha exon, this exon is excluded in most glioblastoma cell transcripts, creating a high-affinity receptor form. In this study, we identified polypyrimidine tract-binding protein (PTB) as a regulator of FGFR-1 splicing. PTB interacted in a sequence-specific manner with the ISS-1 regulatory element in the intron upstream of the a exon. PTB expression was also strongly increased in seven malignant glioblastoma multiforme tumors relative to adjacent normal tissue, but not in a low-grade astrocytoma. These results suggest that increased expression of PTB may contribute to glial cell malignancy.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Transformation, Neoplastic / genetics
  • Exons
  • Gene Expression Regulation, Neoplastic*
  • Glioblastoma / genetics*
  • Glioblastoma / pathology
  • Humans
  • Polypyrimidine Tract-Binding Protein
  • RNA-Binding Proteins / genetics*
  • Receptors, Fibroblast Growth Factor / genetics*
  • Ribonucleoproteins / genetics*
  • Tumor Cells, Cultured

Substances

  • RNA-Binding Proteins
  • Receptors, Fibroblast Growth Factor
  • Ribonucleoproteins
  • Polypyrimidine Tract-Binding Protein